TABLE 3.
Summary of adverse events in all subjects who initiated the n–3 PUFA and corn-oil (control) treatments1
| Control (n = 18) | n–3 PUFA (n = 35) | |
| Definitely or possibly related to treatment, n (%) | ||
| Fishy aftertaste | — | 12 (34.3) |
| Diarrhea | 2 (11.1) | 4 (11.4) |
| Constipation | 1 (5.5) | 2 (5.7) |
| Gastrointestinal discomfort | 2 (11.1) | — |
| Indigestion | — | 3 (8.6) |
| Intestinal gas | — | 1 (2.9) |
| More-frequent bowel movements | — | 1 (2.9) |
| Unlikely related to treatment, n (%) | ||
| Back pain | — | 4 (11.4) |
| Chest pain | — | 2 (5.7) |
| Common cold | 1 (5.5) | — |
| Deep vein thrombosis | 1 (5.5) | — |
| Gastroenteritis | 1 (5.5) | — |
| Memory problems | 1 (5.5) | — |
| Shoulder pain | — | 2 (5.7) |
| Dislocated shoulder | — | 1 (2.9) |
| Neck pain | — | 1 (2.9) |
| Sore elbow | — | 1 (2.9) |
| Sore knee | — | 1 (2.9) |
| Dry skin | — | 1 (2.9) |
| Ear infection | — | 1 (2.9) |
| Facial flushing | — | 1 (2.9) |
| Fatigue | — | 1 (2.9) |
| Melanoma | — | 1 (2.9) |
1
Adverse events are listed for all subjects who initiated n–3 PUFA and corn-oil (control) treatments, including those who dropped out of the study. No adverse events are reported for the 7 subjects who were randomly assigned but did not complete the baseline testing.